Stromal Cell Expression of Caveolin-1 Predicts Outcome in Breast Cancer
- 1 June 2009
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 174 (6), 2035-2043
- https://doi.org/10.2353/ajpath.2009.080924
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotypeBritish Journal of Cancer, 2008
- Evidence for a Role of Tumor-Derived Laminin-511 in the Metastatic Progression of Breast CancerThe American Journal of Pathology, 2007
- Caveolin-1 Mutations in Human Breast CancerThe American Journal of Pathology, 2006
- Biogenesis of caveolae: a structural model for caveolin-induced domain formationJournal of Cell Science, 2006
- Caveolin‐1 is down‐regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breastHistopathology, 2005
- Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancerBreast Cancer Research and Treatment, 2005
- Co-expression of steroid hormone receptors (estrogen receptor α and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: Clinical outcome following tamoxifen-based adjuvant therapyThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001
- Sequence and detailed organization of the human caveolin‐1 and ‐2 genes located near the D7S522 locus (7q31.1)FEBS Letters, 1999